UMIN ID: UMIN000054179
Registered date:17/04/2024
Exploratory study to investigate factors affecting urinary 8-OHdG and diacetylspermine measured by miSignal Check/miSignal Lite
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Healthy adult |
| Date of first enrollment | 2024/04/22 |
| Target sample size | 10000 |
| Countries of recruitment | Japan |
| Study type | Others,meta-analysis etc |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Comparison of urinary concentrations of 8-OHdG and DiAcSpm (creatinine-adjusted) obtained from participants of MySignal Check/MySignal Lite with demographic information. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Subjects whom the principal investigator evaluates unsuitable to participate in this study |
Related Information
| Primary Sponsor | Craif Inc. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Self funded |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Motoki Mikami |
| Address | 5F ITP Hongo Office , 2-25-7 Yushima, Bunkyo-ku, Tokyo, 113-0034, Japan Japan 113-0034 |
| Telephone | 03-6801-8334 |
| clinicaltrial@craif.com | |
| Affiliation | Craif inc. Clinical Development |
| scientific contact | |
| Name | Yuki Ichikawa |
| Address | 5F Hongo ITP Office , 2-25-7 Yushima, Bunkyo-ku, Tokyo, 113-0034, Japan Japan |
| Telephone | 03-6801-8334 |
| clinicaltrial@craif.com | |
| Affiliation | Craif Inc. Chief Technology Officer |